Vicore Pharma Holding AB stock forecast
Vicore Pharma Holding AB (6Y4) Stock Forecast & Price Target
6Y4 Analyst Ratings
6Y4 Stock 12 Month Forecast
Average Price Target
€3.52▲(248.34% Upside)Detailed List of Analyst Forecasts
| Price Target | Article | |||||||
|---|---|---|---|---|---|---|---|---|
| Guggenheim | €3.43→€3.52 | buy | 248.34%Upside | Reiterated | 11/05/26 | |||
| Steven Seedhouse | Cantor Fitzgerald | €2.98 | buy | 194.75%Upside | Initiated | 06/08/26 |
| Rating | Article | ||||
|---|---|---|---|---|---|
| BuyReiterated€3.43→€3.52 | 11/05/26 | 248.34%Upside | |||
| Steven SeedhouseCantor Fitzgerald | BuyInitiated€2.98 | 06/08/26 | 194.75%Upside |
Best Analysts Covering Vicore Pharma Holding AB
Copying Vamil Divan's trades and holding each position for 3 Months would result in 100.00% of your transactions generating a profit, with an average return of +7.23% per trade.
Copying Vamil Divan's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +9.23% per trade.
Copying Vamil Divan's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +9.23% per trade.
6Y4 Analyst Recommendation Trends
| Rating | Jul 26 | Aug 26 | Sep 26 | Oct 26 | Nov 26 |
|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 2 | 2 | 1 | 1 | 1 |
In the current month, 6Y4 has received 1 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. 6Y4 average Analyst price target in the past 3 months is 3.52.
6Y4 Financial Forecast
6Y4 Earnings Forecast
Next quarter’s earnings estimate for 6Y4 is -EUR 0.05 with a range of -EUR 0.05 to -EUR 0.04. The previous quarter’s EPS was -EUR 0.04. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
6Y4 Sales Forecast
Next quarter’s sales forecast for 6Y4 is EUR 73.06K with a range of EUR 0 to EUR 181.51K. The previous quarter’s sales results were EUR 53.91K. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

